Brief: Pharnext Announces Partnership To Evaluate Drugs For Potential Use Against COVID-19

Pharnext SCA

22/04/2020 07:23

April 22 (Reuters) - Pharnext SA  PHARN.PA :
    * PHARNEXT AND THE UNIVERSITY HOSPITAL INSTITUTE
MÉDITERRANÉE
INFECTION ANNOUNCE A JOINT EFFORT TO EVALUATE REPURPOSED DRUGS
FOR POTENTIAL USE AGAINST THE COVID-19 VIRUS
    * JOINT ACTIVITIES WILL FOCUS ON RAPIDLY TESTING ALREADY
APPROVED
DRUGS THAT WERE PREVIOUSLY IDENTIFIED AS POTENTIAL CANDIDATES
FOR FIGHTING COVID-19
    * TESTING WILL BE PERFORMED BY UHI MÉDITERRANÉE INFECTION IN
PRECLINICAL STUDIES AND WILL BUILD UPON GROUNDBREAKING WORK OF
THIS INSTITUTE

Source text for Eikon:  ID:nEQ6lzk6Ha 
Further company coverage:  PHARN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))